En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 10. July 2020
Urologic Neoplasms
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Musculoskeletal System
Endocrine System
Gynecologic Neoplasms
Respiratory Tract
Urologic Neoplasms
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 6445  Previews Next
   Articles 1 - 20 / 128895  
Cancer, Sex Cord Stromal Testicular Tumor

Kapoor M, Budh DP, Kapoor M, Budh DP.
PMID: 32644342 [PubMed]

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
PLoS One
Sandeman K, Eineluoto JT, Pohjonen J, Erickson A, Kilpeläinen TP, Järvinen P, Santti H, Petas A, Matikainen M, Marjasuo S, Kenttämies A, Mirtti T, Rannikko A.
PMID: 32645056 [PubMed - as supplied by publisher]

Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.
World J Urol
Elghazaly H, Mottet N, Garcia J, Oudard S, Roach M, Abbou C, Merseburger A, Emara A, Shehata S, Tawfik H, Khorshid O, Selim A, Assem A, Abdelkarim K, Ezz El-Arab L, Bazarbashi S, Omar A, Elwakil H, Elashry M, Abou ElFotouh M, Osman T, Ezz El Din M.
PMID: 32643031 [PubMed - as supplied by publisher]

Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects.
Strahlenther Onkol
Moll M, Paschen C, Zaharie A, Berndl F, Goldner G.
PMID: 32642874 [PubMed - as supplied by publisher]

CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients.
Kato T, Mizutani K, Kawakami K, Fujita Y, Ehara H, Ito M.
PMID: 32642575 [PubMed]

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.
Commun Biol
Chakravarty D, Nair SS, Hammouda N, Ratnani P, Gharib Y, Wagaskar V, Mohamed N, Lundon D, Dovey Z, Kyprianou N, Tewari AK.
PMID: 32641750 [PubMed - in process]

Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort.
Prostate Cancer Prostatic Dis
Vigneswaran HT, Discacciati A, Gann PH, Grönberg H, Eklund M, Abern MR.
PMID: 32641739 [PubMed - as supplied by publisher]

The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study.
Prostate Cancer Prostatic Dis
Goldberg H, Mohsin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Chandrasekar T, Klaassen Z, Saarela O, Penn L, Alibhai SMH, Fleshner N.
PMID: 32641738 [PubMed - as supplied by publisher]

Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
McFarlane JJ, Kochenderfer MD, Olsen MR, Bauer TM, Molina A, Hauke RJ, Reeves JA, Babu S, Van Veldhuizen P, Somer B, Gunuganti V, Schnadig I, George S, Page RD, Arrowsmith E, Jain RK, Zhang J, McHenry MB, Johansen JL, Vogelzang NJ.
PMID: 32641261 [PubMed - as supplied by publisher]

Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.
BMC Urol
Hsu CW, Chiu YC, Hu HY, Fan YH, Hong SC, Cheng WM.
PMID: 32641099 [PubMed - in process]

Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.
BMC Cancer
Wollersheim BM, van Asselt KM, van der Poel HG, van Weert HCPM, Hauptmann M, Retèl VP, Aaronson NK, van de Poll-Franse LV, Boekhout AH.
PMID: 32641023 [PubMed - in process]

Current Role of Multiparametric MRI and MRI Targeted Biopsies for Prostate Cancer Diagnosis in Germany: A Nationwide Survey.
Urol Int
Saar M, Linxweiler J, Borkowetz A, Fussek S, Urbanova K, Bellut L, Kristiansen G, Wullich B, German Prostate Cancer Consortium (DPKK)..
PMID: 32640460 [PubMed - as supplied by publisher]

The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort.
Muilwijk T, Akand M, Soria F, Giordano A, Milenkovic U, Moris L, Gevaert T, Van Poppel H, Albersen M, Gontero P, Joniau S.
PMID: 32640103 [PubMed - as supplied by publisher]

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.
Cancer Med
Lavalette C, Cordina Duverger E, Artaud F, Rébillard X, Lamy PJ, Trétarre B, Cénée S, Menegaux F.
PMID: 32639678 [PubMed - as supplied by publisher]

Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study.
Int J Cancer
van de Pol JAA, George L, van den Brandt PA, Baldewijns MMLL, Schouten LJ.
PMID: 32638386 [PubMed - as supplied by publisher]

The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial.
Eur J Nucl Med Mol Imaging
Capitanio U, Pepe G, Incerti E, Larcher A, Trevisani F, Lucianò R, Mapelli P, Bettinardi V, Monterisi C, Necchi A, Cascinu S, Bernardi R, Bertini R, Doglioni C, Gianolli L, Salonia A, Picchio M, Montorsi F.
PMID: 32638098 [PubMed - as supplied by publisher]

A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
Contemp Clin Trials Commun
Miyake M, Tanaka N, Asakawa I, Yamaki K, Inoue T, Suzuki S, Hori S, Nakai Y, Anai S, Torimoto K, Toritsuka M, Nakagawa H, Tsukamoto S, Fujii T, Ohbayashi C, Hasegawa M, Kasahara M, Fujimoto K.
PMID: 32637724 [PubMed]

A Tale of Immune-Related Adverse Events With Sequential Trials of Checkpoint Inhibitors in a Patient With Metastatic Renal Cell Carcinoma.
Singh V, Chu Y, Gupta V, Zhao CW.
PMID: 32637277 [PubMed]

Intramedullary craniovertebral junction metastasis leading to the diagnosis of underlying renal cell carcinoma.
Surg Neurol Int
Ponzo G, Umana GE, Giuffrida M, Furnari M, Nicoletti GF, Scalia G.
PMID: 32637205 [PubMed]

Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review.
Ann Med Surg (Lond)
Ziglioli F, Baciarello M, Maspero G, Bellini V, Bocchialini T, Cavalieri D, Bignami EG, Maestroni U.
PMID: 32637083 [PubMed]

   Articles 1 - 20 / 128895    Page 1 of 6445  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1